Search
Menu
Home
HTB
2001
January
HTB
January 2001
Contents
Treatment alerts
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures – worldwide, 1997-2000
US FDA and Bristol-Myers Squibb issue caution for combination HIV therapy with stavudine (d4T) and didanosine (ddI) in pregnant women
Antiretrovirals
HAART initiated during primary HIV infection leads to faster and more complete immune reconstitution
Viral response to antiretroviral therapy slower during acute HIV-1 infection
European Commission approves GlaxoSmithKline’s HIV triple therapy Trizivir
Lamivudine withdrawal may reactivate HBV in HIV-positive patients
CPMP delivers positive opinion on Kaletra
Treatment access
Glaxo blocks importation of generic Combivir into Ghana
Women's health
HIV infection increases susceptibility to Chlamydia trachomatis pelvic inflammatory disease
Pregnancy does not accelerate progression of HIV-1 infection
Human papillomavirus (HPV) may speed HIV progression
Pregnancy
Is the chance to cut a chance to cure? The Caesarean section controversy revisited
Protease inhibitors safe and effective in HIV-positive pregnant women
Paediatric care
Medication adherence poor for many HIV-infected children
Oral ganciclovir safe, effective for children co-infected with CMV and HIV
High cancer incidence in perinatally HIV-infected children
Functional aerobic impairment detected in HIV-seropositive teens
Most untreated African HIV children will die by age 3
Guidelines
French guidelines updated
Side effects
Vitamin based protocol for the treatment for lactic acidosis
Osteonecrosis in HIV
Indinavir nephrolithiasis more prevalent than initially thought
HIV protease inhibitors associated with hepatic cytolysis
Inflammatory stimulus may contribute to HIV lipodystrophy
Coinfections and complications
HIV related oral lesions are less common since HAART
HIV-1 protease inhibitor treatment clears human herpesvirus 8
Cancer and HIV
Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7
Will cidofovir be useful against cervical lesions?
HIV prevention and transmission
Diagnosis of acute HIV infection: it’s time to get moving!
Basic science and immunology
Nef gene defects identified in paediatric long-term HIV survivors
NIH scientists highlight role of macrophages in HIV infection
Chronically infected HIV patients can mount anti-HIV immune response
Structured treatment interruption: important controlled trial in monkeys
Baseline HIV levels, age determine degree of immune restoration with treatment
Anti-HIV CD4+ and CD8+ assay allows rapid estimation of anti-HIV T cell response
Interleukin-7 mediates T-cell homeostasis and increases HIV-1 replication
Other news
Alpha-1 antitrypsin, a natural protein may block HIV
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa
Influenza vaccination does not accelerate HIV infection
Perceived pain in AIDS patients often linked to anxiety, depression
New report on depression in HIV patients
Website for ESPRIT IL-2 study
On the web
Before seroconversion: the clinical and scientific events of acute HIV infection and the immunologic benefits of treatment
The relevance of pharmacologic monitoring in HIV disease
Recent issues in primary HIV: from diagnosis to oral sex transmission
PDFs
Volume 2 Number 1 January/February 2001 PDF
HTB RSS
Early access
Bipolar disorder in people living with HIV
31 October 2024
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
29 October 2024
Mpox breakthrough cases after two doses of the MVA-BN vaccine
29 October 2024
All early access reports
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage